
zzso zzso zzso zzso zzso is a negative regulator of insulin zzso zzso signal zzso and a drug target for treatment of type 2 zzso Using zzso zzso zzso zzso effects of decreased zzso levels on insulin signaling in diabetic zzso mice were zzso zzso zzso prior to zzso resulted in no significant zzso of insulin signaling pathways in zzso from zzso zzso However, in zzso zzso mice, in which zzso protein was decreased by zzso in liver, similar stimulation with insulin resulted in increased zzso zzso of the zzso and zzso zzso zzso and zzso by zzso zzso and zzso zzso zzso zzso zzso activity was also increased zzso zzso zzso B zzso zzso zzso was increased zzso in liver of zzso zzso mice upon insulin zzso while zzso of zzso zzso zzso zzso zzso zzso and zzso was increased more than zzso zzso insulin signaling was increased by zzso zzso as evidenced by increased zzso of zzso in muscle of zzso zzso zzso animals despite the lack of measurable effects on muscle zzso zzso These results indicate that reduction of zzso is sufficient to increase zzso zzso signaling and improve insulin sensitivity in a diabetic animal zzso 

